WHO warns displacement of people in Beirut risks accelerating Covid-19 spread; four new cases in Auckland, New Zealand; Australia suffers deadliest day. Follow the latest updates
- Russia approves vaccine despite testing concerns
- French and Dutch on alert over rise in cases
- Lost on the frontline: the 900 US health workers who have died
- See all our coronavirus coverage
1.24am BST
In other vaccine news, Mexico aims to conduct late-stage clinical trials for Covid-19 vaccines in development by US and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday.
Reuters reports that Mexico has signed memorandums of understanding with Johnson & Johnson, along with Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at a news conference.
Ebrard said the trials would start between September and January, depending on approval from Mexico’s food and drug agency.
He said the goal to secure access to the drugs for Mexico, highlighting growing anxiety and “vaccine diplomacy” around the world as developing countries jostle to get timely access to treatments and vaccines.
The foreign ministry said CanSino and Walvax were interested in producing an eventual vaccine in Mexico for delivery to the Latin American market.
More than 150 vaccines are being developed and tested around the world to stop the Covid-19 pandemic, with 25 in human clinical trials, according to the World Health Organization.
1.11am BST
Russia’s vaccine is administered in two doses and consists of two serotypes of a human adenovirus, each carrying an S-antigen of the new coronavirus, which enter human cells and produce an immune response, Reuters reports.
The platform used for the vaccine was developed by Russian scientists over two decades and had formed the basis for several vaccines in the past, including those against Ebola.
Authorities hope it will allow the Russian economy, which has been battered by fallout from the virus, to return to full capacity.
Kirill Dmitriev, head of Russia’s sovereign wealth fund, said Russia had already received foreign requests for 1bn doses. He said the vaccine was also expected to be produced in Brazil.
Dmitriev said clinical trials were expected to start soon in the United Arab Emirates and the Philippines. Philippine President Rodrigo Duterte has said he is willing to participate personally.
Continue reading…WHO warns displacement of people in Beirut risks accelerating Covid-19 spread; four new cases in Auckland, New Zealand; Australia suffers deadliest day. Follow the latest updatesRussia approves vaccine despite testing concernsFrench and Dutch on alert over rise in casesLost on the frontline: the 900 US health workers who have diedSee all our coronavirus coverage 1.24am BSTIn other vaccine news, Mexico aims to conduct late-stage clinical trials for Covid-19 vaccines in development by US and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday.Reuters reports that Mexico has signed memorandums of understanding with Johnson & Johnson, along with Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at a news conference.Ebrard said the trials would start between September and January, depending on approval from Mexico’s food and drug agency.He said the goal to secure access to the drugs for Mexico, highlighting growing anxiety and “vaccine diplomacy” around the world as developing countries jostle to get timely access to treatments and vaccines.The foreign ministry said CanSino and Walvax were interested in producing an eventual vaccine in Mexico for delivery to the Latin American market.More than 150 vaccines are being developed and tested around the world to stop the Covid-19 pandemic, with 25 in human clinical trials, according to the World Health Organization. 1.11am BSTRussia’s vaccine is administered in two doses and consists of two serotypes of a human adenovirus, each carrying an S-antigen of the new coronavirus, which enter human cells and produce an immune response, Reuters reports. The platform used for the vaccine was developed by Russian scientists over two decades and had formed the basis for several vaccines in the past, including those against Ebola.Authorities hope it will allow the Russian economy, which has been battered by fallout from the virus, to return to full capacity.Kirill Dmitriev, head of Russia’s sovereign wealth fund, said Russia had already received foreign requests for 1bn doses. He said the vaccine was also expected to be produced in Brazil.Dmitriev said clinical trials were expected to start soon in the United Arab Emirates and the Philippines. Philippine President Rodrigo Duterte has said he is willing to participate personally. Continue reading…